EarningsSTERIS's quarterly sales of $1,523 million significantly outpaced consensus and showcased robust organic growth.
Financial PerformanceAdjusted EPS of $2.58 topped Street expectations, reflecting a healthy upward trend in profitability.
Strategic MovesThe sale of the non-core dental business allows STERIS to focus on its core Hospital, Life Sciences, and Applied Sterilization franchises, potentially enhancing overall growth and margins.